Company
Solve Therapeutics
| Industry | clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for solid tumor malignancies |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Solve Therapeutics | Funding | 2025-11-17 |
Company
| Industry | clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for solid tumor malignancies |
|---|
| Company | Round | Date |
|---|---|---|
| Solve Therapeutics | Funding | 2025-11-17 |